封面
市場調查報告書
商品編碼
1601185

藥品無菌轉移市場:依產品、技術、系統類型、可用​​性、滅菌方法、最終用途、應用 - 2025-2030 年全球預測

Pharmaceutical Aseptic Transfer Market by Product, Technology, System Type, Usability, Sterilization Method, End-use, Application - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年藥品無菌轉移市場價值為14.4億美元,預計到2024年將達到15.6億美元,複合年成長率為8.26%,到2030年將達到25.1億美元。

藥品無菌轉移市場涉及物質在無菌環境中的安全轉移和無污染的轉移。該過程在製藥行業中對於保持藥物的純度和有效性極為重要,特別是在製造過程中。無菌運輸的需求在於其能夠防止污染並確保產品完整性,並且在注射劑、生技藥品和疫苗等無菌藥品的生產中發揮關鍵作用。應用範圍涵蓋藥品製造、生物技術和研究實驗室,最終用途包括製造設施、研發實驗室和複方藥房。影響該市場的成長要素包括對生技藥品和生物相似藥的需求不斷增加、藥品生產中對無菌的嚴格監管要求以及無菌運輸技術的進步。一次性系統和自動化解決方案的開發可以提高效率並降低污染風險,從而帶來新的商機。企業應探索靈活運輸系統的創新和物聯網的整合,以加強監控。市場限制包括建立無菌設施的初始投資較高以及遵守不斷變化的監管標準的複雜性。此外,缺乏熟練勞動力以及操作先進系統的潛在技術故障可能是一個挑戰。為了利用成長機會,公司應專注於研究和開發新的滅菌方法和先進材料,在確保無菌的同時提供易用性。建議與監管機構合作並投資培訓計劃,以克服營運挑戰。該市場的特點是眾多大大小小的參與者之間競爭激烈,強調需要透過創新和品質改進實現差異化。此外,對永續和環保實踐的堅定承諾可以與不斷提高的環境意識和永續性法規相一致,並提高競爭力。

主要市場統計
基準年[2023] 14.4億美元
預測年份 [2024] 15.6億美元
預測年份 [2030] 25.1億美元
複合年成長率(%) 8.26%

市場動態:快速發展的藥品無菌轉移市場的關鍵市場洞察

供需的動態交互作用正在改變藥品無菌轉移市場。透過了解這些不斷變化的市場動態,公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 製藥和生物製藥生產活動的增加
    • 存在有關藥品安全和品質的嚴格監管標準
  • 市場限制因素
    • 藥品無菌傳輸系統的製造成本高
  • 市場機會
    • 策略性投資加強契約製造的無菌能力
    • 一次性藥物無菌轉移系統的趨勢日益明顯
  • 市場挑戰
    • 藥品無菌傳輸系統的性能問題

波特五力:駕馭藥品無菌轉移市場的策略工具

波特的五力架構是了解藥品無菌轉移市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點並避免潛在的挑戰,從而確保更強大的市場地位。

PESTLE分析:了解藥品無菌轉移市場的外部影響

外部宏觀環境因素在塑造藥品無菌轉移市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並幫助他們做出積極主動的決策。

市場佔有率分析:了解藥品無菌轉移市場的競爭格局

對藥品無菌轉移市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣:藥品無菌轉移市場供應商的績效評估

FPNV 定位矩陣是評估藥品無菌轉移市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商,從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議:制定藥品無菌轉移市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說,對藥品無菌轉移市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機並取得長期成功。

本報告對市場進行了全面分析,涵蓋關鍵重點領域:

1. 市場滲透率:詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,幫助相關人員做出明智的決策:

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品、區隔市場和地區提供最佳投資機會?

3.塑造市場的主要技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 製藥和生物製藥生產活動的增加
      • 存在有關藥品安全和品質的嚴格監管標準
    • 抑制因素
      • 藥品無菌傳輸系統的製造成本較高
    • 機會
      • 契約製造製造商策略投資,強化無菌操作能力
      • 一次性藥物無菌轉移系統的成長趨勢
    • 任務
      • 製藥無菌傳輸系統的具體性能問題
  • 市場區隔分析
    • 產品:快速推出無菌運輸隔離器,顯著確保無菌性
    • 技術:大力引進自動化無菌輸送系統,方便大量生產
    • 系統類型:擴大採用液體傳輸系統來適應各種批量大小和配方業務。
    • 可用性:多用途系統的使用正在迅速增加,因為從長遠來看它們具有成本效益。
    • 滅菌方法:蒸氣滅菌的使用正在迅速增加,並且由於其廣泛的有效性和效率而成為首選。
    • 最終用途:製藥公司擴大使用藥品無菌傳輸系統
    • 應用:在藥物開發和藥物發現中越來越關注無菌藥物運輸
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 藥品無菌轉移市場:依產品

  • 無菌灌裝/精加工設備
  • 無菌取樣系統
  • 無菌運輸隔離器
  • 無菌輸送幫浦
  • 無菌轉移無菌袋
  • 手套口和袖子

第7章藥品無菌轉移市場:依技術分類

  • 自動無菌輸送系統
  • 手動無菌轉移裝置

第8章依系統類型分類的藥品無菌轉移市場

  • 液體輸送系統
  • 固體傳輸系統

第9章藥品無菌轉移市場:依可用性

  • 多用途
  • 一次性的

第10章 依滅菌方法分類的藥品無菌轉運市場

  • 環氧乙烷 (EtO) 滅菌
  • 過濾除菌
  • 伽瑪射線照射
  • 蒸氣滅菌

第11章藥品無菌轉移市場:依最終用途

  • 生技公司
  • 合約開發和製造組織
  • 醫院/診所
  • 製藥公司

第12章藥品無菌轉移市場:依應用分類

  • 生物安全和品管
  • 臨床診斷
  • 藥物開發和藥物發現
  • 無菌測試

第13章:美洲藥品無菌轉移市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第14章亞太藥品無菌轉移市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第15章歐洲、中東和非洲藥品無菌轉移市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第16章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
    • ChargePoint Technology 在印度設立子公司,提供先進的無菌轉移解決方案
    • ChargePoint Technology 推出用於無菌輸送的機器人物料輸送方案
    • Bora Pharmaceuticals 從 Emergent BioSolutions 收購巴爾的摩製造工廠
    • Syntegon 推出自動沉澱換板裝置以增強無菌生產
    • Syntegon 收購 Telstar 以增強無菌藥物轉移能力
    • AGC Biologics 與 BioConnection 合作加強生物製藥開發和製造
    • ChargePoint 擴大了藥品無菌轉移產品陣容
    • Gemini Bioproducts 推出最先進的無菌保證系統
    • Argonaut 融資 4,500 萬美元用於擴大無菌灌裝和精加工能力
    • Flexicon 液體填充和 Franz Ziel GmbH 推出 Cellefill
    • Sevar Pharma Solutions 擴大高效注射劑的無菌填充能力
    • 塔科馬無菌實驗室和自動化系統合作徹底改變無菌藥物轉移技術
  • 戰略分析和建議
    • 庫斯塔斯有限公司
    • 賽多利斯公司
    • 賽默飛世爾科技有限公司
    • 默克
    • 城巴

公司名單

  • ABC Transfer SAS
  • AdvantaPure by NewAge Industries
  • Atec Pharmatechnik GmbH
  • castus GmbH & Co. KG
  • Catalent, Inc.
  • Central Research Laboratories by Dover Corporation
  • Chargepoint Technology Limited
  • Comecer SpA by ATS Corporation
  • Cytiva by Danaher Corporation
  • Ecolab Inc.
  • Entegris, Inc.
  • Ezi-Dock Systems Limited
  • Fedegari Autoclavi SpA
  • Flexifill Ltd.
  • Germfree Laboratories, Inc.
  • Getinge AB
  • ILC Dover LP by Ingersoll Rand Inc.
  • IMA SpA
  • JCE BIOTECHNOLOGY SAS
  • Merck KGaA
  • OPTIMA Packaging Group GmbH
  • Sartorius AG
  • SKAN Group AG
  • Steriline Srl
  • Syntegon Technology GmbH
  • Tema Sinergie SpA
  • Thermo Fisher Scientific Inc.
  • Watson-Marlow Fluid Technology Solutions by Spirax Group PLC
Product Code: MRR-5C6F41F5B03C

The Pharmaceutical Aseptic Transfer Market was valued at USD 1.44 billion in 2023, expected to reach USD 1.56 billion in 2024, and is projected to grow at a CAGR of 8.26%, to USD 2.51 billion by 2030.

The pharmaceutical aseptic transfer market involves the safe and sterile transfer of materials into or out of a sterile environment without contamination. This process is crucial in the pharmaceutical industry to maintain the purity and efficacy of drugs, especially during manufacturing processes. The necessity of aseptic transfer lies in its ability to prevent contamination and ensure product integrity, playing a vital role in the production of sterile pharmaceuticals such as injectables, biologics, and vaccines. Applications span across pharmaceutical manufacturing, biotechnology, and research laboratories, with end-use sectors including manufacturing facilities, R&D labs, and compounding pharmacies. Growth factors influencing this market include increasing demand for biologics and biosimilars, stringent regulatory requirements for sterility in pharmaceutical production, and advancements in aseptic transfer technologies. Emerging opportunities arise from developments in single-use systems and automation solutions, which can enhance efficiency and reduce contamination risks. Companies should explore innovations in flexible transfer systems and integration of IoT for enhanced monitoring and control. Market limitations include high initial investments for setting up aseptic facilities and the complexity of compliance with evolving regulatory standards. Additionally, the lack of skilled workforce to operate advanced systems and potential technological failures can pose challenges. To leverage growth opportunities, businesses should focus on research and development in novel sterilization methods and advanced materials that ensure sterility yet offer ease of use. Collaborations with regulatory bodies and investment in training programs are recommended to overcome operational challenges. The market is characterized by intense competition with numerous small and large players, emphasizing the need for differentiation through innovation and quality improvement. A keen focus on sustainable and eco-friendly practices can also offer a competitive edge, aligning with growing environmental awareness and regulatory emphasis on sustainability.

KEY MARKET STATISTICS
Base Year [2023] USD 1.44 billion
Estimated Year [2024] USD 1.56 billion
Forecast Year [2030] USD 2.51 billion
CAGR (%) 8.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Aseptic Transfer Market

The Pharmaceutical Aseptic Transfer Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising pharmaceutical and biopharmaceutical production activities
    • Availability of strict regulatory standards for drug safety and quality
  • Market Restraints
    • High cost of manufacturing of pharmaceutical aseptic transfer system
  • Market Opportunities
    • Strategic investments by contract manufacturers to enhance aseptic operation capabilities
    • Increasing inclination toward single-use pharmaceutical aseptic transfer system
  • Market Challenges
    • Certain performance issues with pharmaceutical aseptic transfer system

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Aseptic Transfer Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Aseptic Transfer Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Aseptic Transfer Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Aseptic Transfer Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Aseptic Transfer Market

A detailed market share analysis in the Pharmaceutical Aseptic Transfer Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Aseptic Transfer Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Aseptic Transfer Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Aseptic Transfer Market

A strategic analysis of the Pharmaceutical Aseptic Transfer Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Aseptic Transfer Market, highlighting leading vendors and their innovative profiles. These include ABC Transfer SAS, AdvantaPure by NewAge Industries, Atec Pharmatechnik GmbH, castus GmbH & Co. KG, Catalent, Inc., Central Research Laboratories by Dover Corporation, Chargepoint Technology Limited, Comecer S.p.A. by ATS Corporation, Cytiva by Danaher Corporation, Ecolab Inc., Entegris, Inc., Ezi-Dock Systems Limited, Fedegari Autoclavi S.p.A., Flexifill Ltd., Germfree Laboratories, Inc., Getinge AB, ILC Dover LP by Ingersoll Rand Inc., IMA S.p.A., JCE BIOTECHNOLOGY SAS, Merck KGaA, OPTIMA Packaging Group GmbH, Sartorius AG, SKAN Group AG, Steriline S.r.l., Syntegon Technology GmbH, Tema Sinergie S.p.A., Thermo Fisher Scientific Inc., and Watson-Marlow Fluid Technology Solutions by Spirax Group PLC.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Aseptic Transfer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Aseptic Fill/Finish Equipment, Aseptic Sampling Systems, Aseptic Transfer Isolators, Aseptic Transfer Pumps, Aseptic Transfer Sterile Bags, and Glove Ports & Sleeves.
  • Based on Technology, market is studied across Automated Aseptic Transfer Systems and Manual Aseptic Transfer Devices.
  • Based on System Type, market is studied across Liquid Transfer System and Solid Transfer System.
  • Based on Usability, market is studied across Multiple-Use and Single-Use.
  • Based on Sterilization Method, market is studied across Ethylene Oxide (EtO) Sterilization, Filtration Sterilization, Gamma Irradiation, and Steam Sterilization.
  • Based on End-use, market is studied across Biotechnology Firms, Contract Development & Manufacturing Organizations, Hospitals & Clinics, and Pharmaceutical Companies.
  • Based on Application, market is studied across Biosafety & Quality Control, Clinical Diagnostics, Drug Development & Drug Discovery, and Sterility Testing.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising pharmaceutical and biopharmaceutical production activities
      • 5.1.1.2. Availability of strict regulatory standards for drug safety and quality
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of manufacturing of pharmaceutical aseptic transfer system
    • 5.1.3. Opportunities
      • 5.1.3.1. Strategic investments by contract manufacturers to enhance aseptic operation capabilities
      • 5.1.3.2. Increasing inclination toward single-use pharmaceutical aseptic transfer system
    • 5.1.4. Challenges
      • 5.1.4.1. Certain performance issues with pharmaceutical aseptic transfer system
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Exponential adoption of aseptic transfer isolators providing significant sterility assurance
    • 5.2.2. Technology: Significant adoption of the automated aseptic transfer systems useful for high production volumes
    • 5.2.3. System Type: Rising adoption of liquid transfer systems caters to operations with diverse batch sizes and formulations
    • 5.2.4. Usability: Proliferating use of multiple-use systems owing to their cost-efficiency in the long term
    • 5.2.5. Sterilization Method: Burgeoning utilization of steam sterilization, preferred for its broad-spectrum efficacy and efficiency
    • 5.2.6. End-use: Increasing use of pharmaceutical aseptic transfer systems across pharmaceutical companies
    • 5.2.7. Application: Growing focus on pharmaceutical aseptic transfer for drug development and drug discovery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Aseptic Transfer Market, by Product

  • 6.1. Introduction
  • 6.2. Aseptic Fill/Finish Equipment
  • 6.3. Aseptic Sampling Systems
  • 6.4. Aseptic Transfer Isolators
  • 6.5. Aseptic Transfer Pumps
  • 6.6. Aseptic Transfer Sterile Bags
  • 6.7. Glove Ports & Sleeves

7. Pharmaceutical Aseptic Transfer Market, by Technology

  • 7.1. Introduction
  • 7.2. Automated Aseptic Transfer Systems
  • 7.3. Manual Aseptic Transfer Devices

8. Pharmaceutical Aseptic Transfer Market, by System Type

  • 8.1. Introduction
  • 8.2. Liquid Transfer System
  • 8.3. Solid Transfer System

9. Pharmaceutical Aseptic Transfer Market, by Usability

  • 9.1. Introduction
  • 9.2. Multiple-Use
  • 9.3. Single-Use

10. Pharmaceutical Aseptic Transfer Market, by Sterilization Method

  • 10.1. Introduction
  • 10.2. Ethylene Oxide (EtO) Sterilization
  • 10.3. Filtration Sterilization
  • 10.4. Gamma Irradiation
  • 10.5. Steam Sterilization

11. Pharmaceutical Aseptic Transfer Market, by End-use

  • 11.1. Introduction
  • 11.2. Biotechnology Firms
  • 11.3. Contract Development & Manufacturing Organizations
  • 11.4. Hospitals & Clinics
  • 11.5. Pharmaceutical Companies

12. Pharmaceutical Aseptic Transfer Market, by Application

  • 12.1. Introduction
  • 12.2. Biosafety & Quality Control
  • 12.3. Clinical Diagnostics
  • 12.4. Drug Development & Drug Discovery
  • 12.5. Sterility Testing

13. Americas Pharmaceutical Aseptic Transfer Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Pharmaceutical Aseptic Transfer Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Pharmaceutical Aseptic Transfer Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
    • 16.3.1. ChargePoint Technology launches subsidiary in India for advanced aseptic transfer solutions
    • 16.3.2. ChargePoint Technology unveils robotic material handling solution for aseptic transfer
    • 16.3.3. Bora Pharmaceuticals acquires Baltimore manufacturing facility from Emergent BioSolutions
    • 16.3.4. Syntegon unveils automated settle plate changer for enhanced aseptic manufacturing
    • 16.3.5. Syntegon acquires Telstar to strengthen pharmaceutical aseptic transfer capabilities
    • 16.3.6. AGC Biologics and BioConnection partner for enhanced biopharma drug development and manufacturing
    • 16.3.7. ChargePoint to expand pharmaceutical aseptic transfer product range
    • 16.3.8. Gemini Bioproducts launches cutting-edge aseptic assurance system
    • 16.3.9. Argonaut raises USD 45 Million to enhance aseptic fill/finish capabilities
    • 16.3.10. Flexicon Liquid Filling and Franz Ziel GmbH launched Cellefill
    • 16.3.11. Sever Pharma Solutions expands aseptic filling capacity for high-potency injectables
    • 16.3.12. Germfree Laboratories and Automated Systems of Tacoma collaborate to innovate pharmaceutical aseptic transfer technology
  • 16.4. Strategy Analysis & Recommendation
    • 16.4.1. Castus GmbH & Co.KG
    • 16.4.2. Sartorius AG
    • 16.4.3. Thermo Fisher Scientific Inc.
    • 16.4.4. Merck KGaA
    • 16.4.5. Cytiva

Companies Mentioned

  • 1. ABC Transfer SAS
  • 2. AdvantaPure by NewAge Industries
  • 3. Atec Pharmatechnik GmbH
  • 4. castus GmbH & Co. KG
  • 5. Catalent, Inc.
  • 6. Central Research Laboratories by Dover Corporation
  • 7. Chargepoint Technology Limited
  • 8. Comecer S.p.A. by ATS Corporation
  • 9. Cytiva by Danaher Corporation
  • 10. Ecolab Inc.
  • 11. Entegris, Inc.
  • 12. Ezi-Dock Systems Limited
  • 13. Fedegari Autoclavi S.p.A.
  • 14. Flexifill Ltd.
  • 15. Germfree Laboratories, Inc.
  • 16. Getinge AB
  • 17. ILC Dover LP by Ingersoll Rand Inc.
  • 18. IMA S.p.A.
  • 19. JCE BIOTECHNOLOGY SAS
  • 20. Merck KGaA
  • 21. OPTIMA Packaging Group GmbH
  • 22. Sartorius AG
  • 23. SKAN Group AG
  • 24. Steriline S.r.l.
  • 25. Syntegon Technology GmbH
  • 26. Tema Sinergie S.p.A.
  • 27. Thermo Fisher Scientific Inc.
  • 28. Watson-Marlow Fluid Technology Solutions by Spirax Group PLC

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL ASEPTIC TRANSFER MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. PHARMACEUTICAL ASEPTIC TRANSFER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. PHARMACEUTICAL ASEPTIC TRANSFER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL ASEPTIC TRANSFER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL ASEPTIC TRANSFER MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY ASEPTIC FILL/FINISH EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY ASEPTIC SAMPLING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY ASEPTIC TRANSFER ISOLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY ASEPTIC TRANSFER PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY ASEPTIC TRANSFER STERILE BAGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY GLOVE PORTS & SLEEVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY AUTOMATED ASEPTIC TRANSFER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY MANUAL ASEPTIC TRANSFER DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY LIQUID TRANSFER SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SOLID TRANSFER SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY MULTIPLE-USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY ETHYLENE OXIDE (ETO) STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY FILTRATION STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY GAMMA IRRADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY BIOSAFETY & QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY DRUG DEVELOPMENT & DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030